Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Hanover, Maryland, dedicated to developing innovative therapies for patients with unmet medical needs. The company focuses on advancing its proprietary drug candidates through clinical trials, targeting conditions where current treatment options are limited or ineffective. With a strong commitment to addressing significant health challenges, Processa aims to improve patient outcomes and enhance the quality of life for those affected by debilitating diseases. As it progresses through its development pipeline, the company presents potential investment opportunities in the evolving landscape of healthcare solutions.